156 related articles for article (PubMed ID: 30246734)
21. Lacrimal Gland Involvement in Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome.
Duarte AF; Akaishi PM; de Molfetta GA; Chodraui-Filho S; Cintra M; Toscano A; Silva WA; Cruz AA
Ophthalmology; 2017 Mar; 124(3):399-406. PubMed ID: 27914838
[TBL] [Abstract][Full Text] [Related]
22. Blepharophimosis-ptosis-epicanthus inversus syndrome plus: deletion 3q22.3q23 in a patient with characteristic facial features and with genital anomalies, spastic diplegia, and speech delay.
Zahanova S; Meaney B; Łabieniec B; Verdin H; De Baere E; Nowaczyk MJM
Clin Dysmorphol; 2012 Jan; 21(1):48-52. PubMed ID: 21934608
[TBL] [Abstract][Full Text] [Related]
23. An individual with blepharophimosis-ptosis-epicanthus inversus syndrome (BPES) and additional features expands the phenotype associated with mutations in KAT6B.
Yu HC; Geiger EA; Medne L; Zackai EH; Shaikh TH
Am J Med Genet A; 2014 Apr; 164A(4):950-7. PubMed ID: 24458743
[TBL] [Abstract][Full Text] [Related]
24. Differential apoptotic and proliferative activities of wild-type FOXL2 and blepharophimosis-ptosis-epicanthus inversus syndrome (BPES)-associated mutant FOXL2 proteins.
Kim JH; Bae J
J Reprod Dev; 2014 Mar; 60(1):14-20. PubMed ID: 24240106
[TBL] [Abstract][Full Text] [Related]
25. [Analysis of FOXL2 gene mutation and genotype-phenotype correlation in a Chinese pedigree affected with blepharophimosis-ptosis-epicanthus inversus syndrome].
Cheng H; Wang T; Wang G; Wang J; Shen L; Han M; Yang S; Shi Y; Wang W; Li H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Aug; 35(4):515-517. PubMed ID: 30098246
[TBL] [Abstract][Full Text] [Related]
26. Acquired microcephaly in blepharophimosis-ptosis-epicanthus inversus syndrome because of an interstitial 3q22.3q23 deletion.
Dean SJ; Holden KR; Dwivedi A; Dupont BR; Lyons MJ
Pediatr Neurol; 2014 Jun; 50(6):636-9. PubMed ID: 24725350
[TBL] [Abstract][Full Text] [Related]
27. Characterization of endocrine features and genotype-phenotypes correlations in blepharophimosis-ptosis-epicanthus inversus syndrome type 1.
Nuovo S; Passeri M; Di Benedetto E; Calanchini M; Meldolesi I; Di Giacomo MC; Petruzzi D; Piemontese MR; Zelante L; Sangiuolo F; Novelli G; Fabbri A; Brancati F
J Endocrinol Invest; 2016 Feb; 39(2):227-33. PubMed ID: 26100530
[TBL] [Abstract][Full Text] [Related]
28. Genetic analysis of the FOXL2 gene using quantitative real-time PCR in Chinese patients with blepharophimosis-ptosis-epicanthus inversus syndrome.
Hu S; Guo J; Wang B; Wang J; Zhou Z; Zhou G; Ding X; Ma X; Qi Y
Mol Vis; 2011 Feb; 17():436-42. PubMed ID: 21321671
[TBL] [Abstract][Full Text] [Related]
29. Ovarian Reserve and ART Outcomes in Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome Patients With
Meng T; Zhang W; Zhang R; Li J; Gao Y; Qin Y; Jiao X
Front Endocrinol (Lausanne); 2022; 13():829153. PubMed ID: 35574016
[TBL] [Abstract][Full Text] [Related]
30. Blepharophimosis syndrome with absent tear production.
Ng JK; Stout AU; Aaby AA; Ng JD
Ophthalmic Plast Reconstr Surg; 2015; 31(3):e62. PubMed ID: 24777257
[TBL] [Abstract][Full Text] [Related]
31. The combination of polyalanine expansion mutation and a novel missense substitution in transcription factor FOXL2 leads to different ovarian phenotypes in blepharophimosis-ptosis-epicanthus inversus syndrome (BPES) patients.
Fan J; Zhou Y; Huang X; Zhang L; Yao Y; Song X; Chen J; Hu J; Ge S; Song H; Fan X
Hum Reprod; 2012 Nov; 27(11):3347-57. PubMed ID: 22926839
[TBL] [Abstract][Full Text] [Related]
32. Co-occurrence of congenital hydronephrosis and FOXL2-associated blepharophimosis, ptosis, epicanthus inversus syndrome (BPES).
Gulati R; Verdin H; Halanaik D; Bhat BV; De Baere E
Eur J Med Genet; 2014 Oct; 57(10):576-8. PubMed ID: 25192944
[TBL] [Abstract][Full Text] [Related]
33. Functional study on new FOXL2 mutations found in Chinese patients with blepharophimosis, ptosis, epicanthus inversus syndrome.
Zhou L; Wang J; Wang T
BMC Med Genet; 2018 Jul; 19(1):121. PubMed ID: 30029625
[TBL] [Abstract][Full Text] [Related]
34. [Blepharophimosis-ptosis-epicanthus inversus syndrome].
Lišková P; Ďuďáková Ľ; Diblík P
Cesk Slov Oftalmol; 2016; 72(5):187-190. PubMed ID: 28224805
[TBL] [Abstract][Full Text] [Related]
35. Shifting the landscape: Dominant C-terminal rare missense FOXL2 variants in non-syndromic primary ovarian failure etiology.
Jordan P; Verebi C; Hervé B; Perol S; Chakhtoura Z; Courtillot C; Bachelot A; Karila D; Renard C; Grouthier V; de la Croix SM; Bernard V; Fouveaut C; de la Perrière AB; Jonard-Catteau S; Touraine P; Plu-Bureau G; Dupont JM; Christin-Maitre S; Bienvenu T
Clin Genet; 2024 Jul; 106(1):102-108. PubMed ID: 38558253
[TBL] [Abstract][Full Text] [Related]
36. Blepharophimosis, ptosis, epicanthus inversus syndrome with translocation and deletion at chromosome 3q23 in a black African female.
Alao MJ; Lalèyè A; Lalya F; Hans Ch; Abramovicz M; Morice-Picard F; Arveiler B; Lacombe D; Rooryck C
Eur J Med Genet; 2012 Nov; 55(11):630-4. PubMed ID: 22906557
[TBL] [Abstract][Full Text] [Related]
37. [Phenotype and genetic variant analysis of seven pedigrees affected with blepharophimosis syndrome].
Bai Z; Liu L; Kong X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Nov; 38(11):1060-1063. PubMed ID: 34729743
[TBL] [Abstract][Full Text] [Related]
38. [The mutation study of the FOXL2 gene in a big Chinese family with blepharophimosis-ptosis-epicanthus inversus syndrome].
Tang SJ; Wang XK; Wang YL; Lin LX; Sun Y
Zhonghua Zheng Xing Wai Ke Za Zhi; 2007 Jan; 23(1):48-50. PubMed ID: 17393695
[TBL] [Abstract][Full Text] [Related]
39. Identification of the forkhead transcriptional factor 2 (FOXL2) gene mutations in four Chinese families with blepharophimosis syndrome.
Zhang L; Wang L; Han R; Guan L; Fan B; Liu M; Ying M; Peng H; Li N
Mol Vis; 2013; 19():2298-305. PubMed ID: 24265544
[TBL] [Abstract][Full Text] [Related]
40. Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype--phenotype correlation.
De Baere E; Dixon MJ; Small KW; Jabs EW; Leroy BP; Devriendt K; Gillerot Y; Mortier G; Meire F; Van Maldergem L; Courtens W; Hjalgrim H; Huang S; Liebaers I; Van Regemorter N; Touraine P; Praphanphoj V; Verloes A; Udar N; Yellore V; Chalukya M; Yelchits S; De Paepe A; Kuttenn F; Fellous M; Veitia R; Messiaen L
Hum Mol Genet; 2001 Jul; 10(15):1591-600. PubMed ID: 11468277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]